Abstract
Purpose: Urinary Tract Infections (UTls) occur in 13% of pregnant women, and may present as asymptomatic Bacteriuria (ASB) to symptomatic bladder or kidney infections (Cystitis and Pyelonephritis, respectively). Patients with pre-existing conditions may also be at an increased risk of developing a UTI during pregnancy, thus identifying such risk factors may allow for improved screening techniques and help facilitate preventative medicine in at-risk populations.
Methods: We used the Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 which surveyed postpartum women from 2016 to 2021 to assess factors related to UTIs during pregnancy. PRAMS has respondents self-identifying ethnoracial groups, socioeconomic status (SES), and comorbidities, which we used to identify the associated risk of developing a UTI during pregnancy. Data within PRAMS' Automated Research File (ARF) regarding UTis were only available from 3 states: Delaware, Michigan, and Mississippi after 2017.
Results: From 2018 to 2021, we found a significant decrease in the rates of UTI occurrence from 2018 at 16.35% to a low of 14.02 in 2021; however, rates for UTI in Mississippi were significantly higher than the other two states. We found that individuals experiencing a UTI were significantly more likely to report higher rates of substance use-smoking cigarettes (P<.001) and marijuana (P<.045) and using prescription pain relievers (P<.001) -comorbidities (P<.01) except existing diabetes, and intimate partner violence (P<0001).
Conclusions: Overall, nearly 1 in 6 women reported having a UTI, though rates of UTis in Mississippi were more than twice that of Michigan and Delaware, and the latter two states showed a decreasing trend through this timeframe. Given the relevant significant associations, screening for depression and IPV may be warranted for those presenting with UTI.
Methods: We used the Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 which surveyed postpartum women from 2016 to 2021 to assess factors related to UTIs during pregnancy. PRAMS has respondents self-identifying ethnoracial groups, socioeconomic status (SES), and comorbidities, which we used to identify the associated risk of developing a UTI during pregnancy. Data within PRAMS' Automated Research File (ARF) regarding UTis were only available from 3 states: Delaware, Michigan, and Mississippi after 2017.
Results: From 2018 to 2021, we found a significant decrease in the rates of UTI occurrence from 2018 at 16.35% to a low of 14.02 in 2021; however, rates for UTI in Mississippi were significantly higher than the other two states. We found that individuals experiencing a UTI were significantly more likely to report higher rates of substance use-smoking cigarettes (P<.001) and marijuana (P<.045) and using prescription pain relievers (P<.001) -comorbidities (P<.01) except existing diabetes, and intimate partner violence (P<0001).
Conclusions: Overall, nearly 1 in 6 women reported having a UTI, though rates of UTis in Mississippi were more than twice that of Michigan and Delaware, and the latter two states showed a decreasing trend through this timeframe. Given the relevant significant associations, screening for depression and IPV may be warranted for those presenting with UTI.
Original language | American English |
---|---|
Pages | 18 |
State | Published - 13 Sep 2024 |
Event | 2024 Symposium on Tribal and Rural Innovations in Disparities and Equity for Health - Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation, Tahlequah, United States Duration: 13 Sep 2024 → 13 Sep 2024 |
Conference
Conference | 2024 Symposium on Tribal and Rural Innovations in Disparities and Equity for Health |
---|---|
Abbreviated title | STRIDE 2024 |
Country/Territory | United States |
City | Tahlequah |
Period | 13/09/24 → 13/09/24 |